Telangana DCA Made 54 Seizures Worth Rs 19.35 Lakh In September

Hyderabad: In a major crackdown, the Telangana Drugs Control Administration (DCA) conducted 54 seizures in September, confiscating medicine stocks worth Rs 19.35 lakh.

Of these, 26 cases involved quacks engaged in unlicensed stocking and sale of drugs, while 14 relate to drugs being falsely marketed as food products or nutraceuticals. Additionally, nine raids targeted unlicensed medical shops and godowns, three focused on expired drugs, and one each involved licensed manufacturing violations and banned drugs.

Among the key raids are an operation that took place on September 4, when DCA officials seized medicines worth ₹ 4 lakh from an unlicensed godown in Sangareddy. Later, on September 18, the DCA busted an illegal sale of steroid drugs intended for gym-goers involved in bodybuilding in Hyderabad. Authorities seized steroid medicines worth ₹2 lakh, which were being sold without a valid drug licence.

The Telangana Drugs Control Administration issues drug licences to medical shops and pharmacies under the Drugs and Cosmetics Act, and selling or stocking drugs without a licence can result in imprisonment of up to five years, a release stated.

A review of the DCA’s operations from January 1 to September 30 reveals that during this period, 132 cases were booked for misleading advertisements, 92 cases targeted quacks involved in unlicensed drug sales, and 72 cases were related to price violations under the Drugs (Prices Control) Order. Other cases included 49 for unlicensed drug manufacturing, 34 for marketing drugs as food products or nutraceuticals, six for spurious drug rackets, five for unlicensed cosmetic manufacturing, three for banned drug sales, and one case involving misbranded cosmetics.

Related Posts

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform